Last reviewed · How we verify
NCT03444597: Suprasorb®C
Post-Market Clinical-Follow-Up Study of Suprasorb® C Collagen Wound Dressing
trial in Venous or Mixed Leg Ulcers in 111 participants. Completed in 23 January 2020.
23 January 2020
Quick facts
| Lead sponsor | Lohmann & Rauscher |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 111 |
| Start date | 24 January 2018 |
| Primary completion | 23 January 2020 |
| Estimated completion | 23 January 2020 |
| Sites | 1 location across France |
Conditions studied
- Venous or Mixed Leg Ulcers — all drugs for Venous or Mixed Leg Ulcers →
Sponsor
Lohmann & Rauscher
Who can join
Adults 18 to 85, any sex, with Venous or Mixed Leg Ulcers. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Post-Market Clinical-Follow-Up Study of Suprasorb® C collagen wound dressing
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03444597
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Lohmann & Rauscher trials
Trials by the same sponsor.
- NCT07211243 — Suprasorb®X+PHMB Pro vs Suprasorb®X+PHMB in Treatment of Infected Venous Leg Ulcers · NA · recruiting
- NCT07316556 — Post-Marketing Surveillance of Vliwazell® Prowound Dressing · recruiting
- NCT05646121 — Suprasorb® A + Ag in the Treatment of Wounds at Risk of Infection and Infected Wounds · completed
- NCT03897465 — Lomatuell Pro® Versus UrgoTul® in the Management of Acute Wounds · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03444597 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lohmann & Rauscher
- Last refreshed: 19 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03444597.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing